Positron emission tomography--positive distal femur following fludarabine, dexamethasone and mitoxantrone chemotherapy.
Benson
G M
GM
Regional Haematology Unit, Belfast City Hospital, Belfast, North Ireland. gary@beechfoeld32.freeserve.co.uk
Clarke
J
J
Wilson
L
L
Murtagh
E
E
Kettle
P J
PJ
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D005269:Femur / Q000473:pathology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects*; D010020:Osteonecrosis / Q000139:chemically induced* / Q000473:pathology; D049268:Positron-Emission Tomography / Q000379:methods; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D003907:Dexamethasone; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine